Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial Evaluating the Efficacy of Conventional Two-Needle Arthrocentesis Versus Surgery-Guided Arthrocentesis in the Management of Temporomandibular Joint Disorders
The goal of this clinical trial is to compare two methods of arthrocentesis in treating temporomandibular joint (TMJ) disorders. The main questions it aims to answer are: Is surgery-guided arthrocentesis more efficient in terms of operation time compared to traditional two-needle arthrocentesis? Does the use of surgical guides lead to less postoperative pain and better patient comfort? Participants will: Undergo either the traditional two-needle arthrocentesis or the surgery-guided arthrocentesis. Be monitored for operation time, postoperative pain, and overall patient comfort. Researchers will compare the outcomes of patients who underwent traditional two-needle arthrocentesis with those who had surgery-guided arthrocentesis to see if the latter can shorten operation time and improve patient comfort.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Marmara University School of Dentistry
Istanbul, Turkey (Türkiye)
Start Date
September 10, 2023
Primary Completion Date
February 10, 2024
Completion Date
February 10, 2024
Last Updated
July 12, 2024
20
ACTUAL participants
Traditional Two-Needle Arthrocentesis
PROCEDURE
Surgery-Guided Arthrocentesis
PROCEDURE
Lead Sponsor
Marmara University
NCT03991728
NCT07317570
NCT05006963
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions